<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="81620">
  <stage>Registered</stage>
  <submitdate>27/09/2006</submitdate>
  <approvaldate>3/10/2006</approvaldate>
  <actrnumber>ACTRN12606000423516</actrnumber>
  <trial_identification>
    <studytitle>A pilot study of the pharmacokinetics, efficacy, and acceptability of a novel nicotine inhaler in smokers</studytitle>
    <scientifictitle>A pilot study of the pharmacokinetics, affect on Smoking Urges, and acceptability of a novel nicotine inhaler in smokers</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Tobacco use disorder</healthcondition>
    <healthcondition>Nicotine addiction</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Addiction</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Cross over study.  Interventions: on the first day one smoked cigarette, on the second day 1 inhalation of 50 micrograms of nicotine inhaler every 30s for 5 minutes, on the third day 1 inhalation of 100 micrograms of nicotine inhaler every 30s for 5 min.  This allows for a 24-hour wash-out</interventions>
    <comparator />
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Pharmacokinetics of nicotine</outcome>
      <timepoint>At time = 0, 1, 5, 10, 15, 30 minutes</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Acceptability, Cigarette Evaluation Scale, Questionnaire of Smoking Urges.</outcome>
      <timepoint>Assessed immediately after administration.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Smoked &gt;10 cigarettes per day.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Recent use of other nicotine replacement therapy such as bupropion; cardiovascular, psychiatric history of note.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>None</concealment>
    <sequence>1st day= cigarette, 2nd day=50mcg, 3rd day=100mcg</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Pharmacokinetics</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1</phase>
    <anticipatedstartdate>2/10/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>10</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Professor Julian Crane</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Asthma &amp; Respiratory Foundation of New Zealand</fundingname>
      <fundingaddress />
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>Wellington School of Medicine</sponsorname>
      <sponsoraddress />
      <sponsorcountry>New Zealand</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>A pilot study to test the hypothesis that this novel nicotine inhaler will provide a pharmacokinetic profile very similar to that produced by smoking a cigarette and thus will be effective in reducing smoking urges</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Central Regional Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec>CEN06/04026</hrec>
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Professor Julian Crane</name>
      <address>Wellington School of Medicine
23A Mein Street
Newtown Wellington</address>
      <phone>+61 4 3855541</phone>
      <fax />
      <email>crane@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Brent Caldwell</name>
      <address>Wellington School of Medicine
23A Mein Street
Newtown Wellington</address>
      <phone>+64 4 3855541</phone>
      <fax />
      <email>brent.caldwell@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>